Rafat Abonour

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

S. Vincent Rajkumar, Susanna Jacobus, Natalie S. Callander et al. · The Lancet Oncology · 2009 · 933 citations · Full text

Medicine, Hematology, Oncology +11

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

Shaji Kumar, J H Lee, Juan José Lahuerta et al. · Leukemia · 2011 · 721 citations

Medicine, Hematology, Pharmacotherapy +15

High-Dose Chemotherapy and Stem-Cell Rescue for Metastatic Germ-Cell Tumors

Lawrence H. Einhorn, Stephen D. Williams, Amy R. Chamness et al. · New England Journal of Medicine · 2007 · 493 citations · Full text

Medicine, Cancer Biology, Oncology +16

Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells

Rafat Abonour, David A. Williams, Lawrence H. Einhorn et al. · Nature Medicine · 2000 · 277 citations

Life Sciences, Biotechnology, Genetics +13

A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma

Don M. Benson, Craig C. Hofmeister, Attaya Suvannasankha et al. · Blood · 2012 · 238 citations · Full text

Medicine, Immunology, Oncology +10